Last updated: 07/28/2020 13:10:05
Expansion of Interpretation Guidelines for the COPD Assessment Test (CAT), Level Of Impact Scores in Primary Care Centers in the US
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Expansion of Interpretation Guidelines for the COPD Assessment Test (CAT), Level Of Impact Scores in Primary Care Centers in the US
Trial description: Expansion of Interpretation Guidelines for the COPD Assessment Test (CAT), Level Of Impact Scores in Primary Care Centers in the US
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
2017-19-09
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Richard H Stanford, Maggie Tabberer, Mark Kosinski, Phaedra T Johnson, John White, Maureen Carlyle, Nicole A Tillery. HO-14-14653 Assessment of the COPD Assessment Test within US primary care. Chronic Obstr Pulm Dis (Miami). 2020;7(1):26-37
DOI: 10.15326/jcopdf.7.1.2019.0135
PMID: 31999900
Medical condition
Pulmonary Disease, Chronic Obstructive
Product
fluticasone furoate, fluticasone furoate/vilanterol, vilanterol
Collaborators
OptumInsights
Study date(s)
January 2016 to September 2017
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Protocol
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
2017-19-09
Actual study completion date
2017-19-09
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website